New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Corbus Pharmaceuticals Holdings, Inc.

Contributing Author

Recent Articles by Corbus Pharmaceuticals Holdings, Inc.

Oct-07	Corbus Pharmaceuticals to Participate in the Upcoming Piper Sandler Virtual Oncology Symposium CRBP GlobeNewswire
Sep-22	Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ESMO 2025 CRBP GlobeNewswire
Sep-16	FDA Grants Fast Track Designation to Corbus Pharmaceuticals' Nectin-4 Targeting ADC CRB-701 in Head and Neck Squamous Cell Carcinoma CRBP GlobeNewswire
Aug-05	Corbus Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides a Corporate Update CRBP GlobeNewswire
Jul-30	Corbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress CRBP GlobeNewswire
Jun-30	Corbus Pharmaceuticals Initiates Multiple Ascending Dose Portion of Phase 1 Study of Highly Peripherally Restricted CB1 Inverse Agonist CRB-913 for the Treatment of Obesity CRBP GlobeNewswire
Jun-25	Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab CRBP GlobeNewswire
Jun-24	Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium CRBP GlobeNewswire
May-22	Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference CRBP GlobeNewswire
May-19	Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair CRBP GlobeNewswire
May-08	Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference CRBP GlobeNewswire
May-06	Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update CRBP GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.